Aurinia Pharmaceuticals Inc. AUPH
15.48 USD -0.25 (-1.59%)
Regular-session close
15.40 -0.08 -0.52%
Pre-market · Nov 17, 7:00 AM ET
15.30 Day range 15.81
13.52 52-week range 19.25
- YTD
- -2.95%
- 1 year
- +0.85%
Discussion (239)
Just WOW
Who’d be selling now
No guts no glory! Simple as that!
Big mistake !!!
Benlysta was approved sooner bc its already in market for SLE. It’s NOT an entire new therapy. Patients w sle are already on it but not for LN. This old drug, which is unimpressive. Just got another new indication with slight advantage.
I hope this will approved next year or else too much tax to pay. Unfortunately This will get approved very soon
Crazy how this ALWAYS SELLS OFF... all these shares traded and price has stayed the same for 9 months
The time has come !
Run Forrest run ! What a bunch of sissies !
DONT cry for me Argentiiina !!
